Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexapro for prevention of post-ICU depression
NCT00872027Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Apr 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in major depressive disorder (MDD), sponsored by University of Minnesota. Primary endpoint: Recruitment Feasibility at 2 days. Started Apr 2009; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00872027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872027.